SUNVAX MRNA THERAPEUTICS Trademark
Trademark Overview
On Friday, July 28, 2023, a trademark application was filed for SUNVAX MRNA THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the SUNVAX MRNA THERAPEUTICS trademark a serial number of 98107092. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, July 16, 2024. This trademark is owned by SUNVAX MRNA THERAPEUTICS INC.. The SUNVAX MRNA THERAPEUTICS trademark is filed in the Chemical Products category with the following description:
Lipids used in the manufacture of cosmetics, beverages, food products and food supplements for industry and scientific use; Nucleotides for scientific and industrial research use in the nature of mRNA and lipid nanoparticle-mRNA; nanoparticles for industrial purposes and scientific use, namely, lipid nanoparticles for mRNA delivery
General Information
Serial Number | 98107092 |
Word Mark | SUNVAX MRNA THERAPEUTICS |
Filing Date | Friday, July 28, 2023 |
Status | 688 - NOTICE OF ALLOWANCE - ISSUED |
Status Date | Tuesday, July 16, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
Published for Opposition Date | Tuesday, May 21, 2024 |
Trademark Statements
Description of Mark | The mark consists of an image of the sun in orange, bordered in yellow with a partially shaded blue helical strand superimposed on blue wings followed by the words "SUNVAX MRNA THERAPEUTICS" in blue. The color white represents background or transparency only and is not part of the mark. |
Pseudo Mark | SUN VAX MRNA THERAPEUTICS |
Indication of Colors claimed | The color(s) blue, orange and yellow is/are claimed as a feature of the mark. |
Goods and Services | Lipids used in the manufacture of cosmetics, beverages, food products and food supplements for industry and scientific use; Nucleotides for scientific and industrial research use in the nature of mRNA and lipid nanoparticle-mRNA; nanoparticles for industrial purposes and scientific use, namely, lipid nanoparticles for mRNA delivery |
NOT AVAILABLE | "MRNA THERAPEUTICS" |
Classification Information
International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
US Class Codes | 001, 005, 006, 010, 026, 046 |
Class Status Code | 6 - Active |
Class Status Date | Monday, August 28, 2023 |
Primary Code | 001 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
Party Name | SUNVAX MRNA THERAPEUTICS INC. |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 03 - Corporation |
Address | Beverly, MA 01915 |
Party Name | SUNVAX MRNA THERAPEUTICS INC. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Beverly, MA 01915 |
Trademark Events
Event Date | Event Description |
Tuesday, August 1, 2023 | NEW APPLICATION ENTERED |
Monday, August 28, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Tuesday, August 29, 2023 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
Friday, March 29, 2024 | ASSIGNED TO EXAMINER |
Wednesday, April 10, 2024 | NON-FINAL ACTION WRITTEN |
Wednesday, April 10, 2024 | NON-FINAL ACTION E-MAILED |
Wednesday, April 10, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Monday, April 15, 2024 | EXAMINERS AMENDMENT -WRITTEN |
Monday, April 15, 2024 | EXAMINERS AMENDMENT E-MAILED |
Monday, April 15, 2024 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
Monday, April 15, 2024 | EXAMINER'S AMENDMENT ENTERED |
Monday, April 15, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Wednesday, May 1, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Tuesday, May 21, 2024 | PUBLISHED FOR OPPOSITION |
Tuesday, May 21, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, July 16, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |